4.7 Review

The liver X receptor: A master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease

期刊

BIOCHEMICAL PHARMACOLOGY
卷 86, 期 1, 页码 96-105

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bcp.2013.03.016

关键词

Oxysterol; Liver X receptor; Steatosis; NAFLD; NASH

资金

  1. Institut National de la Recherche Agronomique (INRA)
  2. Region Midi-Pyrenees
  3. Agence Nationale de la Recherche (ANR-CRISALIS OBELIP)

向作者/读者索取更多资源

Since it is associated to the obesity epidemic, non alcoholic fatty liver disease (NAFLD) has become a major public health issue. NAFLD ranges from benign hepatic steatosis, i.e. abnormally elevated triglyceride accumulation, to non alcoholic steatohepatitis (NASH) that can lead to irreversible liver damages. The search for pharmacological and dietary approaches to treat or prevent NAFLD has pointed at nuclear receptors as sensible targets. Indeed, nuclear receptors are ligand-sensitive transcription factors that play a central role in hepatic lipid metabolism. Among nuclear receptors, the liver X receptor has been identified as an oxysterol receptor. It is involved in the control of various aspects of lipid metabolism that are reviewed in this manuscript. We highlight the role of LXR in the gut-liver axis and the studies that have provided a rationale for strategies specifically targeting the hepatic activity of LXR in NAFLD. (C) 2013 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据